Breast augmentation falls in the areas of plastic and reconstructive surgery and gynecology (Heden, 2006). The operations are usually done for purely aesthetic reasons. The result is called colloquially silicone breasts, since most implants are made of silicone. The average age of the patients decreases continuously from year to year. Half of the women operated on in 2005 were less than 25 years, 2% under 18 years old (Aliyev, 2008). At the same time, the volume is bigger on the younger side. A breast augmentation is often a medically indicated surgery. This is partly the case, if there is a disfiguring malformation of the female breast, which is a disease in the sense of the Social Code. Dow Corning is a U.S. company specializing in the technology of silicones. It is the world leader in technology and innovations in the field of silicones. Dow Corning offers powerful solutions to meet the most diverse of more than 25,000 customers worldwide, with over 7000 products and services. The company is owned equally by The Dow Chemical Company and Corning, Incorporated, and generates more than half its annual sales outside the United States. There has been a lot of controversy in recent times relating implants of this company with breast cancer risks. Countless lawsuits and government bans have been seen in different parts of the world, especially Europe (Cunningham, 2009). In this context, the parties at risks are the countless women who have used implants or intend to do so in future. They are prone to the risks of implants. Also, considering that the risks are just rumors, their decision to opt for implants get influenced by the rumors. The other stakeholders include the people involved with Dow Corning, from investors to staffs (Yoshimura, 2007).
隆胸落在整形外科和妇科领域（海曾，2006）。这些操作通常是纯粹审美的原因了。其结果是被称为通俗的硅胶乳房植入物，由于大部分是由硅。患者的平均年龄每年不断减小。的女性手术2005半是小于25岁，2%在18岁（阿利耶夫，2008）。同时，体积大的年轻的一面。隆胸手术往往是一个医学指征的手术。这是事情的一部分，如果有一个难看的畸形的女性的乳房，这是社会规范的感病。道康宁公司是一家美国公司专业从事有机硅技术。它是在有机硅领域世界领先的技术和创新。道康宁提供强大的解决方案以满足最广泛的全球25000多家客户，超过7000的产品和服务。公司拥有同样的陶氏化学公司和康宁公司，注册成立，并产生超过一半的年销售在美国以外的国家。目前已在最近几次有关争议颇多的植入物本公司与乳腺癌的风险。无数的诉讼和政府的禁令已见于世界各地，特别是欧洲的（坎宁安，2009）。在这样的背景下，风险的双方是无数的妇女使用的植入物或打算将来做。他们倾向于风险的植入物。同时，考虑到风险只是传言，他们的选择决定植入物被传言的影响。其他的利益相关者包括参与道康宁的人们，从投资者的人员（吉村，2007）。
